Low 68F
Many studies evaluating Tirzepatide, Retatrutide and other investigational peptides continue to use Semaglutide as the primary comparator, making it central to understanding how newer incretin therapies differ from established GLP-1 receptor agonism
Methods We used a subset of Truveta Data to identify patients aged 18 years or older with overweight or obesity (defined as BMI over 27) and at least one medication dispense (i.e., prescription filled at a pharmacy) for a GLP-1 RA between January 2025 and July 2025
This window is when the medication reaches its peak concentration, often manifesting as temporary nausea, diarrhea, constipation, or abdominal bloating
Doctronic.ai telehealth platform makes it easy to receive personalized guidance and discuss any questions about Mucinex or other congestion-relief medications
Treatment Options at Shed ShedRx offers a wide range of compounded GLP-1 treatments in different formats, making it more flexible than many other clinics
